<DOC>
	<DOC>NCT00595309</DOC>
	<brief_summary>The objective is to assess the effect of a booster vaccination on immunogenicity of IC51 in terms of seroconversion rate.</brief_summary>
	<brief_title>Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<criteria>Main Healthy adults who completed the primary immunization in study IC51 309 Male and female healthy subjects aged at least 18 years with written informed consent and either no childbearing potential or negative pregnancy test Main â€¢ History of immunodeficiency or immunosuppressive therapy, known Human Immunodeficiency Virus (HIV), or drug addiction including alcohol dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>